Refining Active Surveillance Eligibility in Intermediate-risk Non–muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence

In this study, we looked at patients with bladder cancer who might be monitored (active surveillance) without immediate treatment. We found that if the cancer comes back within 6 mo, there is a higher chance that it will become more aggressive.

Authors

Institutions

Publication Details

Journal
European Urology Open Science
Published
2025-11-08
DOI
https://doi.org/10.1016/j.euros.2025.10.017
Citations
1
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refining Active Surveillance Eligibility in Intermediate-risk Non–muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence

Giuseppe Carrieri, Roberto Contieri, Ugo Giovanni Falagario, Gian Maria Busetto et al.
1 citations
European Urology Open Science
Bladder and Urothelial Cancer Treatments
2.01
article

Refining Active Surveillance Eligibility in Intermediate-risk Non–muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence

Giuseppe Carrieri, Roberto Contieri, Ugo Giovanni Falagario, Gian Maria Busetto, Nicola Schiavone, Marco Finati, Anna Ricapito, Francesco Cinelli, Antonio Fanelli, Richard LJ Naspro, Ciro Imbimbo, Nicola d’Altilia, Savio Domenico Pandolfo, Benjamin Pradere, Biagio Barone, Luigi Cormio, Felice Crocetto
article en
1 citations

Abstract

In this study, we looked at patients with bladder cancer who might be monitored (active surveillance) without immediate treatment. We found that if the cancer comes back within 6 mo, there is a higher chance that it will become more aggressive.

European Urology Open ScienceVol. 82
University of Foggia (IT), University of L'Aquila (IT), Karolinska Institutet (SE), Ospedale L. Bonomo (IT), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Naples Federico II (IT)
Openalex Percentile: Top 10%
Bladder and Urothelial Cancer Treatments
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.